CCO Treatment Updates

Drug Resistance in Chronic Hepatitis B: From Definitions to Management Strategies

Defining HBV Resistance: Interpreting and Applying Clinical Data

Module 1 of 1

Faculty:
Paul Martin, MD

CME CREDIT INFORMATION

Release Date: 11/05/07

Expiration Date: 11/04/08

Physicians: maximum of 2.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Paul Martin, MD, reviews the treatment of patients with chronic hepatitis B, focusing on drug resistance.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the various definitions of hepatitis B virus resistance used in various clinical studies and treatment guidelines
Explain strategies to prevent the emergence of resistance
Discuss the management of resistance in patients with chronic hepatitis B

Virtual Presentations

A Case-Based Approach to Managing Resistance in Chronic HBV Infection

Faculty:
Emmet B. Keeffe, MD, MACP

CME CREDIT INFORMATION

Release Date: 01/08/08

Expiration Date: 01/07/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Emmet B. Keeffe, MD, MACP, reviews steps to prevent, identify and manage HBV resistance to oral agents.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the definitions of HBV resistance used in various clinical studies and treatment guidelines
Explain how to use definitions of HBV resistance to interpret clinical data
Discuss the management of resistance in patients with chronic hepatitis B

CCO Slideset

A Case-Based Approach to Managing Resistance in Chronic HBV Infection

Emmet B. Keeffe, MD, MACP, reviews steps to prevent, identify and manage HBV resistance to oral agents.

Format: Microsoft PowerPoint (.ppt) | File size: 2,204 KB

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.